Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy. Issue 6 (June 2022)
- Record Type:
- Journal Article
- Title:
- Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy. Issue 6 (June 2022)
- Main Title:
- Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy
- Authors:
- Zhang, Wenjie
Taheri-Ledari, Reza
Ganjali, Fatemeh
Afruzi, Fereshte Hassanzadeh
Hajizadeh, Zoleikha
Saeidirad, Mahdi
Qazi, Fateme Sadat
Kashtiaray, Amir
Sehat, Samin Sadat
Hamblin, Michael R.
Maleki, Ali - Abstract:
- Abstract: Nanobioconjugates are nanoscale drug delivery vehicles that have been conjugated to or decorated with biologically active targeting ligands. These targeting ligands can be antibodies, peptides, aptamers, or small molecules such as vitamins or hormones. Most research studies in this field have been devoted to targeting cancer. Moreover, the nanostructures can be designed with an additional level of targeting by being designed to be stimulus-responsive or "smart" by a judicious choice of materials to be incorporated into the hybrid nanostructures. This stimulus could be an acidic pH, raised temperature, enzyme, ultrasound, redox potential, an externally applied magnetic field, or laser irradiation. In this case, the smart capability can increase the accumulation at the tumor site or the on-demand drug release, while the ligand ensures selective binding to the tumor cells. The present review highlights some interesting studies classified according to the nanostructure material. These materials include natural substances (polysaccharides), multi-walled carbon nanotubes (and halloysite nanotubes), metal-organic frameworks and covalent-organic frameworks, metal nanoparticles (gold and silver), and polymeric micelles. Graphical abstract: Image 1 Highlights: Recent developments in the field of drug delivery systems is reviewed. A logical classification for the nano-sized porous materials is submitted. Conjugated proteins to the surface of nano-carriers are investigated.Abstract: Nanobioconjugates are nanoscale drug delivery vehicles that have been conjugated to or decorated with biologically active targeting ligands. These targeting ligands can be antibodies, peptides, aptamers, or small molecules such as vitamins or hormones. Most research studies in this field have been devoted to targeting cancer. Moreover, the nanostructures can be designed with an additional level of targeting by being designed to be stimulus-responsive or "smart" by a judicious choice of materials to be incorporated into the hybrid nanostructures. This stimulus could be an acidic pH, raised temperature, enzyme, ultrasound, redox potential, an externally applied magnetic field, or laser irradiation. In this case, the smart capability can increase the accumulation at the tumor site or the on-demand drug release, while the ligand ensures selective binding to the tumor cells. The present review highlights some interesting studies classified according to the nanostructure material. These materials include natural substances (polysaccharides), multi-walled carbon nanotubes (and halloysite nanotubes), metal-organic frameworks and covalent-organic frameworks, metal nanoparticles (gold and silver), and polymeric micelles. Graphical abstract: Image 1 Highlights: Recent developments in the field of drug delivery systems is reviewed. A logical classification for the nano-sized porous materials is submitted. Conjugated proteins to the surface of nano-carriers are investigated. Protein engineering for preparation of modern drug carriers is reviewed. Nano-bioconjugates as state-of-the-art in selective cancer therapy are discussed. Abstract : Biotechnology; Ligands for molecular recognition; Targeted cancer therapy; Synergistic therapeutic effects; High-tech nanostructures; Nanotechnology. … (more)
- Is Part Of:
- Heliyon. Volume 8:Issue 6(2022)
- Journal:
- Heliyon
- Issue:
- Volume 8:Issue 6(2022)
- Issue Display:
- Volume 8, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 8
- Issue:
- 6
- Issue Sort Value:
- 2022-0008-0006-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-06
- Subjects:
- Biotechnology -- Ligands for molecular recognition -- Targeted cancer therapy -- Synergistic therapeutic effects -- High-tech nanostructures -- Nanotechnology
Research -- Periodicals
Medical sciences -- Periodicals
Natural history -- Periodicals
Social sciences -- Periodicals
Earth sciences -- Periodicals
Physical sciences -- Periodicals
507.2 - Journal URLs:
- http://www.sciencedirect.com/science/journal/24058440/ ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.heliyon.2022.e09577 ↗
- Languages:
- English
- ISSNs:
- 2405-8440
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22235.xml